NCI Inc (NASDAQ:NCIT)‘s stock had its “buy” rating reiterated by equities researchers at Noble Financial in a research report issued to clients and investors on Friday, May 12th.

A number of other research firms have also recently commented on NCIT. FBR & Co reaffirmed a “hold” rating and issued a $11.00 target price on shares of NCI in a research report on Tuesday, April 4th. Cowen and Company reaffirmed a “buy” rating and issued a $16.50 target price on shares of NCI in a research report on Monday, April 10th. Finally, Zacks Investment Research cut shares of NCI from a “hold” rating to a “sell” rating in a research report on Saturday, April 8th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. NCI currently has a consensus rating of “Buy” and a consensus price target of $13.75.

NCI (NASDAQ NCIT) traded up 0.52% during mid-day trading on Friday, hitting $19.50. 47,721 shares of the stock traded hands. The company has a market cap of $264.24 million, a P/E ratio of 43.62 and a beta of 1.02. The company’s 50 day moving average is $16.41 and its 200 day moving average is $14.43. NCI has a 12 month low of $10.98 and a 12 month high of $19.75.

NCI (NASDAQ:NCIT) last announced its quarterly earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. NCI had a net margin of 4.06% and a return on equity of 12.10%. The firm had revenue of $78.75 million for the quarter, compared to analysts’ expectations of $76.55 million. On average, analysts expect that NCI will post $1.01 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “NCI’s (NCIT) “Buy” Rating Reaffirmed at Noble Financial” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/06/05/nci-inc-ncit-stock-rating-reaffirmed-by-noble-financial-updated-updated.html.

A number of hedge funds have recently modified their holdings of NCIT. Stanley Laman Group Ltd. raised its stake in shares of NCI by 5.5% in the third quarter. Stanley Laman Group Ltd. now owns 13,329 shares of the information technology services provider’s stock worth $154,000 after buying an additional 700 shares during the period. Algert Global LLC raised its stake in NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares during the last quarter. Teachers Advisors LLC raised its stake in NCI by 44.1% in the fourth quarter. Teachers Advisors LLC now owns 13,212 shares of the information technology services provider’s stock worth $184,000 after buying an additional 4,044 shares during the last quarter. Hancock Holding Co. purchased a new stake in NCI during the first quarter worth $189,000. Finally, Russell Investments Group Ltd. purchased a new stake in NCI during the fourth quarter worth $216,000. Institutional investors own 34.36% of the company’s stock.

NCI Company Profile

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

Receive News & Stock Ratings for NCI Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc and related stocks with our FREE daily email newsletter.